Request Free Sample
×
South Korea Biomarker Technologies Market
ID: MRFR/HC/54482-HCR
200 Pages
June 2025
South Korea Biomarker Technologies Market Research Report: By Product (Consumables, Instruments), By Profiling Technology (PCR, Imaging Technology, NGS), By Application (Cancer, Infectious Disease) andBy Research Area (Genomics, Proteomics)- Forecast to 2035
Industry Developments
Recent news developments in the South Korea Biomarker Technologies Market have highlighted significant advancements and increased investment in the sector. Companies like Korea Biobank and Medytox are expanding their Research and Development efforts to enhance biomarker discovery and diagnostics. Lunit announced collaborations aimed at advancing AI and imaging technologies, aiming to optimize cancer diagnostics. In July 2023, Hanmi Pharmaceutical made notable strides with new biomarker-based therapies targeting specific conditions. Seegene also continues to grow, focusing on diagnostic innovations amidst rising demand. Current affairs indicate a competitive landscape with medtech firms such as MediKine and LG Chem enhancing their molecular diagnostic solutions. Green Cross Corporation is making efforts in vaccine and therapeutic developments associated with biomarkers. Notably, in September 2023, Samsung Biologics entered a strategic partnership with Nara Biotech to co-develop innovative biomarker-based technologies. The continuous growth in market valuation is supported by the increasing need for precision medicine, which drives investments in biomarker technologies. Over the last few years, substantial emphasis on genetic research, evidenced by collaborations and funding in bioanalytics, has fueled advancements in the South Korean biotechnology landscape.
Report Scope
Report Scope:
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 695.49(USD Million) |
| MARKET SIZE 2024 | 751.2(USD Million) |
| MARKET SIZE 2035 | 1502.4(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.504% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Korea Biobank, Medytox, Lunit, Hanmi Pharmaceutical, Precision Medicine, Seegene, MediKine, LG Chem, Green Cross Corporation, Nara Biotech, Bioasis Technologies, SNUH Biomedical Research Institute, Pharmicell, Samsung Biologics |
| SEGMENTS COVERED | Product, Profiling Technology, Application, Research Area |
| KEY MARKET OPPORTUNITIES | Advanced diagnostics development, Personalized medicine growth, Increasing research funding, Rising disease prevalence, Biotechnology collaboration expansion |
| KEY MARKET DYNAMICS | Rising prevalence of chronic diseases, Increasing investment in R&D, Demand for personalized medicine, Advancements in genomics technology, Growing adoption of point-of-care testing |
| COUNTRIES COVERED | South Korea |
FAQs
What is the expected market size of the South Korea Biomarker Technologies Market in 2024?
The South Korea Biomarker Technologies Market is expected to be valued at 751.2 million USD in 2024.
What is the projected market value for the South Korea Biomarker Technologies Market by 2035?
By 2035, the South Korea Biomarker Technologies Market is projected to reach a value of 1502.4 million USD.
What is the expected CAGR for the South Korea Biomarker Technologies Market between 2025 and 2035?
The anticipated compound annual growth rate (CAGR) for the South Korea Biomarker Technologies Market is 6.504% from 2025 to 2035.
Which companies are considered key players in the South Korea Biomarker Technologies Market?
Major players in the South Korea Biomarker Technologies Market include Korea Biobank, Medytox, Lunit, and Hanmi Pharmaceutical among others.
What was the market value of consumables in the South Korea Biomarker Technologies Market in 2024?
In 2024, the market value of consumables within the South Korea Biomarker Technologies Market is estimated at 350.0 million USD.
What is the projected market value for consumables by 2035?
By 2035, the market for consumables in the South Korea Biomarker Technologies Market is anticipated to grow to 700.0 million USD.
What was the market value for instruments in the South Korea Biomarker Technologies Market in 2024?
The market value for instruments in the South Korea Biomarker Technologies Market is expected to be 401.2 million USD in 2024.
What is the anticipated market value for instruments by 2035?
The projected market value for instruments in the South Korea Biomarker Technologies Market is 802.4 million USD by 2035.
What are the key growth drivers for the South Korea Biomarker Technologies Market?
Key growth drivers include advancements in medical research and increasing demand for personalized medicine in South Korea.
How does the South Korea Biomarker Technologies Market trend towards regional growth?
The South Korea Biomarker Technologies Market is experiencing robust growth driven by both local companies and increasing investments in biotechnology.
Download Free Sample
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
Noah Malgeri
Co-Founder
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
Joseph Aguayo
Sales Operations & Pricing Manager
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
Peter Groot koerkamp
Account and Business Manager
“Thank you, this will be very helpful for OQS.”
La Terria Dodd
Program Support Specialist
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
Younghwan Choi
Senior Retail Manager
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Mark Irwin
Management Consultant
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Akif Moroglu
Strategy & Business Development Director
Case Study
Aerospace & Defense
Leave a Comment